We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Automated Systems Detect Variant Hemoglobins

By LabMedica International staff writers
Posted on 13 Apr 2011
The detection performance of automated high-pressure liquid chromatography (HPLC) systems for variant hemoglobins has been compared. More...


The HPLC systems have become the method of choice for the evaluation of patients suspected with hemoglobinopathies, but they vary in their performance and ability to discriminate variant hemoglobins.

Scientists at the University of California Davis Health System, (Sacramento, CA, USA), evaluated the performance of two HPLC methods used in the detection of common hemoglobin (Hb) variants. They tested 377 samples, of which 99 were from patents with HbS, 32 with HbC, 78 with other hemoglobin variants or thalassemia, and 11 with increased hemoglobin A1c. The interpretations of each chromatograph produced by the HPLC systems were compared.

The two systems were the Variant, (Bio-Rad Laboratories, Hercules, CA, USA), and the Ultra2, (Trinity Biotech, Kansas City, MO, USA). Both the Variant and Ultra2 methods use a relatively short program that measures the separation process over approximately 4–6 minutes. The Ultra2 has a secondary feature that will reflex repeat test samples with abnormal peaks or unusual findings using a high-resolution method that observes the separation process over 6-8 minutes, allowing for better separation of the hemoglobin peaks.

There were no differences noted for hemoglobins A0, S, or C. There were significant differences between the HPLC methods for hemoglobins F, A2, and A1c. However, there was good concordance between normal and abnormal interpretations (97.9% and 96.2%, respectively). The authors concluded that both the Variant and Ultra2 HPLC methods were able to detect most common hemoglobin variants. There was better discrimination for fast hemoglobins, between hemoglobins E and A2, and between hemoglobins S and F using the Ultra2 HPLC method.

Hemoglobin variants are a result of genetic changes resulting in abnormal or dys-synchronous hemoglobin chain production, as in thalassemia or the generation of hemoglobin chain variants such as hemoglobin S, as seen in sickle cell anemia.

Automated high-pressure liquid chromatography (HPLC) systems have become the method of choice for the evaluation of hemoglobinopathies. With this method, samples are mixed with buffers and salts and injected through an ion exchange column where physical properties of the hemoglobin such as surface charge and hydrophilic group, are separated during migration. HPLC methods allow for better isolation of hemoglobin variants and are less subjective than electrophoretic methods.

The study was published in the April 2011 edition of the International Journal of Laboratory Hematology.

Related Links:

Bio-Rad Laboratories
Trinity Biotech
UC Davis



Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
New
DNA/RNA Extraction/Purification Kit
Nucleic Acid Extraction or Purification Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Immunology

view channel
Image: The Volition Nu.Q nucleosome assay runs on the IDS i10 automated analyzer platform (Photo courtesy of VolitionRx)

Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes

Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.